You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Adoptive cellular therapy

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hematologic Malignancy, Blood Cancer, Lymphoma Trial in Boston (Palliative Care, Usual Care)

Recruiting
  • Hematologic Malignancy
  • +4 more
  • Palliative Care
  • Usual Care
  • Boston, Massachusetts
    Massachusetts General Hospital Cancer Center
Jan 24, 2023

Malignant Glioma, High Grade Glioma Trial in Birmingham, Washington, Gainesville (TTRNA-DC vaccines with GM-CSF,

Recruiting
  • Malignant Glioma
  • High Grade Glioma
  • TTRNA-DC vaccines with GM-CSF
  • +4 more
  • Birmingham, Alabama
  • +2 more
Feb 2, 2023

Rapid Autopsy and Procurement of Cancer Tissue

Recruiting
  • Thymus Tumors
  • +4 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Aug 20, 2022

    SARS-CoV-2 Specific T Cells in Patients With Severe COVID-19

    Recruiting
    • COVID-19
    • Blood donation from convalescent donor
    • Singapore, Singapore
    • +1 more
    Mar 29, 2022

    Neuroblastoma, Diffuse Intrinsic Pontine Glioma Trial in Gainesville, Charlotte (Tumor-specific ex vivo expanded autologous

    Recruiting
    • Neuroblastoma
    • Diffuse Intrinsic Pontine Glioma
    • Tumor-specific ex vivo expanded autologous lymphocyte transfer (TTRNA-xALT)
    • Gainesville, Florida
    • +1 more
    Apr 20, 2022

    Acute Myeloid Leukemia Trial (TCB008)

    Recruiting
    • Acute Myeloid Leukemia
    • Bristol, United Kingdom
    • +5 more
    Jan 10, 2023

    Diffuse Intrinsic Pontine Glioma (DIPG), Brain Stem Glioma Trial in Gainesville (TTRNA-DC vaccines with GM-CSF, TTRNA-xALT,

    Recruiting
    • Diffuse Intrinsic Pontine Glioma (DIPG)
    • Brain Stem Glioma
    • TTRNA-DC vaccines with GM-CSF
    • +5 more
    • Gainesville, Florida
      UF Health Shands Children's Hospital
    Apr 29, 2022

    Cancer, Solid Tumor Trial in Houston (drug, biological, diagnostic test)

    Completed
    • Cancer
    • Solid Tumor
    • Houston, Texas
      University of Texas MD Anderson Cancer Center
    Jan 14, 2022

    Merkel Cell Polyomavirus Infection, Stage IV Merkel Cell Carcinoma AJCC v7 Trial in Seattle (drug, other, biological, radiation)

    Terminated
    Has Results
    • Merkel Cell Polyomavirus Infection
    • Stage IV Merkel Cell Carcinoma AJCC v7
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Feb 25, 2022

    Renal Cell Carcinoma, Urothelial Carcinoma Trial in Oklahoma City (Bone Marrow Aspirate)

    Terminated
    • Renal Cell Carcinoma
    • Urothelial Carcinoma
    • Bone Marrow Aspirate
    • Oklahoma City, Oklahoma
      Stephenson Cancer Center
    Jul 8, 2021

    COL6A3 Positive, HLA-A*0201 Positive Cells Present, PRAME Positive Trial in Houston (biological, drug, procedure)

    Active, not recruiting
    • COL6A3 Positive
    • +3 more
    • Aldesleukin
    • +4 more
    • Houston, Texas
      M D Anderson Cancer Center
    Sep 22, 2022

    Colorectal Adenocarcinoma, Metastatic Cholangiocarcinoma, Metastatic Colorectal Carcinoma Trial in Houston (biological, drug,

    Terminated
    • Colorectal Adenocarcinoma
    • +12 more
    • Adoptive Immunotherapy
    • +4 more
    • Houston, Texas
      M D Anderson Cancer Center
    Oct 28, 2020

    COVID-19 Trial in Singapore (SARS-CoV-2 Specific T Cells)

    Recruiting
    • COVID-19
    • SARS-CoV-2 Specific T Cells
    • Singapore, Singapore
    • +4 more
    Jul 2, 2020

    Hepatocellular Carcinoma Trial in Beijing (adoptive immunotherapy, MWA)

    Completed
    • Hepatocellular Carcinoma
    • adoptive immunotherapy
    • MWA
    • Beijing, Beijing, China
      Chinese PLA General Hospital
    Mar 2, 2021

    Progressive Multifocal Leukoencephalopathy Trial run by the National Institute of Neurological Disorders and Stroke (NINDS)

    Completed
    • Progressive Multifocal Leukoencephalopathy
    • PyVST
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 24, 2023

    B Cell Leukemia Trial in Seattle (Autologous CD19 CAR+ EGFTt + T cells)

    Active, not recruiting
    • B Cell Leukemia
    • Autologous CD19 CAR+ EGFTt + T cells
    • Seattle, Washington
      Seattle Children's Hospital
    Feb 15, 2022

    Peripheral T Cell Lymphoma (PTCL), Cell Therapy Trial in United States (MT-101, MT-101 + Conditioning (Lymphodepleting)

    Recruiting
    • Lymphoma, T-Cell, Peripheral
    • +4 more
    • MT-101
    • MT-101 + Conditioning (Lymphodepleting) Chemotherapy
    • Duarte, California
    • +8 more
    Jan 27, 2023

    Peripheral Blood Mononuclear Cells From Healthy People for

    Recruiting
    • Healthy Volunteer
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Aug 20, 2022

      HNSCC, Melanoma, Gynecologic Cancer Trial in Portland (DP CD8 TIL, DP CD8 TIL KD, Low dose IL-2)

      Recruiting
      • HNSCC
      • +5 more
      • DP CD8 TIL
      • +2 more
      • Portland, Oregon
        Providence Portland Medical Center
      Jun 5, 2023

      Multiple Sclerosis Trial in Nantes (Cellular therapy with EBV specific autologous CTL infusion)

      Recruiting
      • Multiple Sclerosis
      • Cellular therapy with EBV specific autologous CTL infusion
      • Nantes, France
        University Hospital
      Jan 27, 2021

      Pancreatic Cancer Trial in Shanghai (Stereotactic body radiation therapy plus vNKT cell adoptive therapy)

      Recruiting
      • Pancreatic Cancer
      • Stereotactic body radiation therapy plus vNKT cell adoptive therapy
      • Shanghai, China
        Changhai Hospital affiliated to Naval Medical University
      Mar 13, 2023

      MDS Trial in San Diego (PACTN)

      Unknown status
      • Myelodysplastic Syndromes
      • PACTN
      • San Diego, California
        University of California, San Diego
      Mar 3, 2020

      Urothelial Carcinoma, Non-Invasive Bladder Urothelial Carcinoma Trial in Tampa (Adoptive Cell Therapy with Tumor-infiltrating

      Recruiting
      • Urothelial Carcinoma
      • Non-Invasive Bladder Urothelial Carcinoma
      • Adoptive Cell Therapy with Tumor-infiltrating Lymphocytes (TIL)
      • Tampa, Florida
        Moffitt Cancer Center
      Mar 2, 2023

      Platinum-Resistant Fallopian Tube Carcinoma, Platinum-Resistant Ovarian Carcinoma, Platinum-Resistant Primary Peritoneal

      Active, not recruiting
      • Platinum-Resistant Fallopian Tube Carcinoma
      • +11 more
      • Aldesleukin
      • +3 more
      • Buffalo, New York
        Roswell Park Cancer Institute
      Jul 13, 2022

      Measures (PROMs) in Adoptive Cell Therapy (ACT) Setting

      Not yet recruiting
      • Cancer
        • (no location specified)
        Feb 7, 2023